Long-term Morbidity of Testicular Cancer Treatment
- 1 August 2015
- journal article
- research article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 42 (3) , 393-408
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Second Malignant Neoplasms and Cardiovascular Disease Following RadiotherapyJNCI: Journal of the National Cancer Institute, 2012
- Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Heart Journal, 2010
- Testicular Cancer Survivorship: Research Strategies and RecommendationsJNCI: Journal of the National Cancer Institute, 2010
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer SurvivorsJNCI: Journal of the National Cancer Institute, 2009
- Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancerActa Oncologica, 2008
- Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional studyJournal of Translational Medicine, 2007
- Is the Sexual Function Compromised in Long-Term Testicular Cancer Survivors?European Urology, 2007
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007
- Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer SurvivorsJournal of Clinical Oncology, 2007
- Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of CancerJournal of Clinical Oncology, 2005